| http://www.w3.org/ns/prov#value | - (INR) =< 1.7 (not required for patients on anticoagulation agents; patients who are being therapeutically anticoagulated with an agent such as Coumadin or heparin will be allowed to participate provided that no prior evidence of underlying abnormality in these parameters exists) Sponsor:National Cancer Institute (NCI)Dates:February 2010Last Updated:December 4, 2014Study HIC#:Clinicaltrials.gov ID
|
